Jessica M Stempel

11PUBLICATIONS
67CO-AUTHORS
Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)HaematologyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 06, 2026
Impact of Metformin on the Incidence of Thrombosis in Older Adults with Polycythemia Vera or Essential Thrombocythemia and Diabetes.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Dec 03, 2025
Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database.

Jessica M Stempel, Rong Wang, Alfred I Lee

|Sep 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis.

Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles

|Aug 14, 2025
Advances and Challenges in the Management of Myelodysplastic Syndromes.

Jessica M Stempel, Tariq Kewan, Amer M Zeidan

|Jul 28, 2025
Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Nikolai A Podoltsev

Pageof 2

Frequent Collaborators

5 joint publications

Nikolai A Podoltsev

4 joint publications

Lourdes Mendez

3 joint publications

Rory M Shallis

3 joint publications

Abdulrahman Alhajahjeh